High Blood Pressure (Hypertension) Completed Phase 4 Trials for Irbesartan (DB01029)

Also known as: HTN / Hypertension(HTN) / Hypertensive / Hypertension / High Blood Pressure / Blood High Pressure / Blood Pressure, High / Blood pressure high / Essential (primary) hypertension / HT / HBP / Hypertension NOS / Hypertension arterial

IndicationStatusPhase
DBCOND0040789 (High Blood Pressure (Hypertension))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00110422Irbesartan in the Treatment of Hypertensive Patients With Metabolic SyndromeTreatment
NCT00224549PHARES Study: Management of Resistant HypertensionTreatment
NCT00264212AMISH : Aprovel for Management of Isolated Systolic HypertensionTreatment
NCT00265967Irbesartan in HypertensionTreatment
NCT00283036APROVE : Irbesartan in HypertensionTreatment
NCT00335673I SAVE - Irbesartan in Mild to Moderate Hypertensive PatientsTreatment
NCT00334581Irbesartan in Chinese Hypertensive Diabetics With MicroalbuminuriaTreatment
NCT00350038Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial FunctionsTreatment
NCT00362037I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular HypertrophyTreatment
NCT00362258I PREVENT - Irbesartan In Hypertensive Diabetic PatientsTreatment
NCT00443612Irbesartan/Hydrochlorothiazide National Taiwan University Hospital ListingTreatment
NCT00500604Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate HypertensionTreatment
NCT00529750Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With HypertensionTreatment
NCT00549133Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing AtenololTreatment
NCT00564187Evaluation of Efficacy and Safety of the Dosage Adjustment of AprovelĀ® (Irbesartan) in Hypertensive Outpatients in Current Clinical PracticeTreatment
NCT00562809The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild HypertensionTreatment
NCT00670566Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive PatientsTreatment
NCT00708344ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide CombinationTreatment
NCT00847834Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese PopulationTreatment